Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial.

Blamey RW, Bates T, Chetty U, Duffy SW, Ellis IO, George D, Mallon E, Mitchell MJ, Monypenny I, Morgan DA, Macmillan RD, Patnick J, Pinder SE.

Eur J Cancer. 2013 Jul;49(10):2294-302. doi: 10.1016/j.ejca.2013.02.031. Epub 2013 Mar 21.

PMID:
23523089
2.

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.

Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM; PRIME II investigators.

Lancet Oncol. 2015 Mar;16(3):266-73. doi: 10.1016/S1470-2045(14)71221-5. Epub 2015 Jan 28. Erratum in: Lancet Oncol. 2015 Mar;16(3):e105.

PMID:
25637340
3.

Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.

Benchalal M, Le Prisé E, de Lafontan B, Berton-Rigaud D, Belkacemi Y, Romestaing P, Peignaux K, Courdi A, Monnier A, Montcuquet P, Goudier MJ, Marchal C, Chollet P, Abadie-Lacourtoisie S, Datchary J, Veyret C, Kerbrat P.

Cancer. 2005 Jul 15;104(2):240-50.

4.

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Goel S, Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004562. doi: 10.1002/14651858.CD004562.pub4. Review.

PMID:
19821328
5.

The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer.

Fowble B, Fein DA, Hanlon AL, Eisenberg BL, Hoffman JP, Sigurdson ER, Daly MB, Goldstein LJ.

Int J Radiat Oncol Biol Phys. 1996 Jul 1;35(4):669-77.

PMID:
8690632
6.

Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.

Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, Sigurdson E, Boraas M, Goldstein L.

Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1005-15.

PMID:
10421533
7.

Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrence.

Winzer KJ, Sauer R, Sauerbrei W, Schneller E, Jaeger W, Braun M, Dunst J, Liersch T, Zedelius M, Brunnert K, Guski H, Schmoor C, Schumacher M; German Breast Cancer Study Group.

Eur J Cancer. 2004 May;40(7):998-1005.

PMID:
15093574
8.

Successful management of elderly breast cancer patients treated without radiotherapy.

Valassiadou K, Morgan DA, Robertson JF, Pinder SE, Cheung KL.

World J Surg Oncol. 2007 Jun 3;5:62.

9.

Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen.

Kontos M, Allen DS, Agbaje OF, Hamed H, Fentiman IS.

Eur J Surg Oncol. 2011 Dec;37(12):1051-8. doi: 10.1016/j.ejso.2011.07.005. Epub 2011 Aug 16.

PMID:
21843919
10.

Does the placement of surgical clips within the excision cavity influence local control for patients treated with breast-conserving surgery and irradiation.

Fein DA, Fowble BL, Hanlon AL, Hoffman JP, Sigurdson ER, Eisenberg BL.

Int J Radiat Oncol Biol Phys. 1996 Mar 15;34(5):1009-17.

PMID:
8600083
11.

Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment.

Livi L, Paiar F, Saieva C, Scoccianti S, Dicosmo D, Borghesi S, Agresti B, Nosi F, Orzalesi L, Santini R, Barca R, Biti GP.

Radiother Oncol. 2007 Mar;82(3):287-93. Epub 2006 Dec 22.

PMID:
17188382
12.

Radiotherapy and tamoxifen after breast-conserving surgery for DCIS.

Cunnick GH, Mokbel K.

Int J Fertil Womens Med. 2004 Sep-Oct;49(5):237-8. Review.

PMID:
15633483
13.

Radiation therapy and tamoxifen after breast-conserving surgery: updated results of a 2 x 2 randomised clinical trial in patients with low risk of recurrence.

Winzer KJ, Sauerbrei W, Braun M, Liersch T, Dunst J, Guski H, Schumacher M; German Breast Cancer Study Group (GBSG).

Eur J Cancer. 2010 Jan;46(1):95-101. doi: 10.1016/j.ejca.2009.10.007.

PMID:
19879131
14.

Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer.

Dalberg K, Mattsson A, Sandelin K, Rutqvist LE.

Breast Cancer Res Treat. 1998 May;49(1):69-78.

PMID:
9694613
15.
16.

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD004562. doi: 10.1002/14651858.CD004562.pub3. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD004562.

PMID:
18843661
17.

Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer.

Fyles AW, McCready DR, Manchul LA, Trudeau ME, Merante P, Pintilie M, Weir LM, Olivotto IA.

N Engl J Med. 2004 Sep 2;351(10):963-70.

18.

Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.

van Hezewijk M, Bastiaannet E, Putter H, Scholten AN, Liefers GJ, Rea D, Hasenburg A, Paridaens R, Hozumi Y, Markopoulos C, Seynaeve C, Jones SE, Marijnen CA, van de Velde CJ.

Radiother Oncol. 2013 Aug;108(2):190-6. doi: 10.1016/j.radonc.2013.08.020. Epub 2013 Sep 14.

PMID:
24044798
20.

Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.

Fisher BJ, Perera FE, Cooke AL, Opeitum A, Stitt L.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):117-23.

PMID:
9747828

Supplemental Content

Support Center